Search

Your selections:

Subfield Toxicology Remove constraint Subfield: Toxicology Start Over

Search Results

Sakala, M'sanide
2015·Master of Public Health·University of Zambia

The World Bank (1994) noted that over 80% of the original budget on health in most African countries is lost through inefficient practices at various levels, by various accountability failures in the supply chain for medical supplies. There have been reports of thefts, with no counter claims of...

Download PDF ↓
Chilinde, Bonaventure
2013·University of Zambia

The Pharmaceutical industry in general requires a well outlined laws to ensure proper control. The Zambian pharmaceutical industry is not an exception to this. The law governing the industry in Zambia is the Pharmaceutical Act No. 14 of 2004 which repealed the 'Pharmacy and Poisons Act, 1940' and...

Download PDF ↓
Mulundika, Jacqueline I.M
2012·Masters·University of Zambia

This prospective study carried out in the Casualty Unit of the Department of Surgery at the University Teaching Hospital is an effort to document the role of alcohol in road traffic accidents. It examines the presence of alcohol in blood samples of one hundred consenting road traffic accident...

Download PDF ↓
Mbolela, Mulenga Ronnet
2012·University of Zambia

Illicit drugs are, today, a world concern and Zambia, being part of the global village has not been spared. Global drug trends indicate that there has been stability in the cultivation and production of illicit drugs. However, the stability has been to the varying production trends in various...

Download PDF ↓
Alutuli, Luke
2012·Master of Public Health·University of Zambia

The problem of counterfeiting of drugs presents an enormous public health challenge. No area of the world is unaffected, but mounting evidence shows that the problem is disproportionately severe in developing and emerging market countries, which also have a high burden of infectious diseases such...

Download PDF ↓
Zyambo, Rabson
2012·Masters·University of Zambia

The production of substandard and counterfeit drugs as a result of non-adherence to good manufacturing practices by pharmaceutical companies is a vast and underreported worldwide problem particularly affecting developing countries. Developing countries are not only markets for substandard and...

Download PDF ↓